AGOSTINIS, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 10.193
EU - Europa 6.779
AS - Asia 5.055
SA - Sud America 601
Continente sconosciuto - Info sul continente non disponibili 535
AF - Africa 182
OC - Oceania 27
AN - Antartide 1
Totale 23.373
Nazione #
US - Stati Uniti d'America 9.955
SG - Singapore 1.779
PL - Polonia 1.458
IT - Italia 1.370
CN - Cina 1.008
DE - Germania 952
SE - Svezia 611
VN - Vietnam 537
RU - Federazione Russa 504
HK - Hong Kong 445
BR - Brasile 443
GB - Regno Unito 399
UA - Ucraina 322
FR - Francia 299
BD - Bangladesh 275
KR - Corea 262
FI - Finlandia 196
NL - Olanda 171
IN - India 149
TR - Turchia 133
IE - Irlanda 123
CA - Canada 116
BG - Bulgaria 95
JP - Giappone 78
MA - Marocco 60
TW - Taiwan 60
AR - Argentina 53
MX - Messico 53
ID - Indonesia 45
BE - Belgio 42
ZA - Sudafrica 38
AT - Austria 35
IQ - Iraq 35
ES - Italia 30
PK - Pakistan 27
IR - Iran 25
PH - Filippine 25
CL - Cile 24
AU - Australia 22
CH - Svizzera 22
EG - Egitto 21
SA - Arabia Saudita 21
EC - Ecuador 20
SN - Senegal 20
AE - Emirati Arabi Uniti 19
UZ - Uzbekistan 19
CZ - Repubblica Ceca 18
VE - Venezuela 17
HU - Ungheria 16
MY - Malesia 16
PT - Portogallo 16
RO - Romania 16
CO - Colombia 15
TH - Thailandia 15
IL - Israele 14
AZ - Azerbaigian 13
LT - Lituania 13
PE - Perù 13
TT - Trinidad e Tobago 13
PY - Paraguay 10
CR - Costa Rica 9
DK - Danimarca 9
JM - Giamaica 9
DZ - Algeria 8
MD - Moldavia 8
OM - Oman 8
PA - Panama 8
SI - Slovenia 8
TN - Tunisia 8
EU - Europa 7
GR - Grecia 7
EE - Estonia 6
GT - Guatemala 6
HN - Honduras 6
JO - Giordania 6
KE - Kenya 6
KZ - Kazakistan 6
NO - Norvegia 6
HR - Croazia 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
RS - Serbia 5
CI - Costa d'Avorio 4
ET - Etiopia 4
GE - Georgia 4
LB - Libano 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
AL - Albania 3
BB - Barbados 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
Totale 22.812
Città #
Warsaw 1.353
Ashburn 1.202
Singapore 1.080
Fairfield 848
Woodbridge 588
Ann Arbor 560
Chandler 554
San Jose 528
Houston 425
Hong Kong 409
Trieste 402
Seattle 379
Dallas 375
Wilmington 364
Cambridge 267
Seoul 253
Beijing 245
Jacksonville 245
Council Bluffs 209
Hefei 170
Boardman 165
Los Angeles 164
Ho Chi Minh City 158
Princeton 146
Santa Clara 146
Columbus 127
New York 127
Chicago 124
The Dalles 123
Hanoi 117
Dublin 101
Moscow 100
Sofia 93
Helsinki 84
London 83
Lauterbourg 82
Frankfurt am Main 80
Izmir 80
Buffalo 79
Milan 76
Zgierz 74
Munich 64
Dearborn 56
Taipei 55
São Paulo 51
Shanghai 48
Casablanca 46
Atlanta 43
Falls Church 43
Tokyo 42
Düsseldorf 39
North Bergen 39
San Diego 36
Dong Ket 34
Brussels 33
Phoenix 33
Rome 32
Menlo Park 31
Amsterdam 30
Turku 29
Guangzhou 28
Toronto 28
Orem 27
Boston 26
Da Nang 26
Saint Petersburg 26
Stockholm 26
Redmond 25
Venice 25
Des Moines 24
Montreal 24
Nanjing 24
Redwood City 24
Brooklyn 23
Fort Wayne 23
Nuremberg 23
Miano 21
Redondo Beach 21
Chennai 20
Dakar 20
Jakarta 20
San Francisco 20
Treviso 20
Vienna 20
Washington 20
Denver 18
Jinan 18
Johannesburg 18
Kyiv 18
Lappeenranta 18
Arzene 17
Baghdad 17
Bern 17
Udine 17
Duino-Aurisina 16
Haiphong 15
Mexico City 15
Poplar 15
Tashkent 15
Belo Horizonte 14
Totale 14.401
Nome #
The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 866
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation 524
RelB activation in anti-inflammatory decidual endothelial cells: a master plan to avoid pregnancy failure? 495
Pharmacokinetics and immunomodulatory effect of lipophilic Echinacea extract formulated in softgel capsules 460
The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis 448
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 410
C1q as a novel player in angiogenesis with therapeutic implication in wound healing 372
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 361
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 343
C1q is involved in human trophoblast invasion 329
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 329
C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation 324
Pre-eclampsia affects procalcitonin production in placental tissue 320
Analysis of anti-C1q antibodies in normal and pathological pregnancies 320
Pathological significance and prognostic value of surfactant protein D in cancer 316
Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells 312
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 309
C1q is associated with a reduced inflammatory response of decidual endothelial cells 308
C1q is responsible of the anti-inflammatory behavior of decidual endothelial cells 296
Pre-eclampsia is associated with defective production of C1q by invasive trophoblast 296
Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells 284
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 284
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 279
Alternative functions of the complement protein C1q at embryo implantation site 271
The first trimester gravid serum regulates procalcitonin expression in human macrophages skewing their phenotype in vitro. 266
null 263
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 262
Combined extracts of Echinacea angustifolia DC. and Zingiber officinale Roscoe in softgel capsules: Pharmacokinetics and immunomodulatory effects assessed by gene expression profiling 259
Analysis of the cAMP-PCT-CGRP axis in normal and pathological pregnancy 257
Chemerin Regulates NK Cell Accumulation and Endothelial Cell Morphogenesis in the Decidua during Early Pregnancy 257
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 252
Vitreous Prostaglandin E2 Changes after Topical Administration of Diclofenac 0.1%, Indomethacin 0.5%, Nepafenac 0.3%, and Bromfenac 0.09. 252
The role of complement component C1q in angiogenesis 242
Evaluation of Sars-CoV-2 entry receptors in COVID-19 positive and negative placentae: correlation between expression and infectivity 242
A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia 236
COMPLEMENT PROTEIN C1Q PRODUCTION IN MALIGNANT PLEURAL MESOTHELIOMA 231
The seventh complement component is expressed on endothelial cells membrane and exerts an anti-inflammatory action 218
THE CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCES OF C1Q EXPRESSION IN GLIOMAS: A BIOINFORMATICS ANALYSIS 217
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 216
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 216
Preeclampsia is associated with defective production of C1q by invasive trophoblast 206
In vivo distribution of {beta}2 glycoprotein I under various pathophysiological conditions 205
Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating 204
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 204
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 203
Human recombinant lysozyme downregulates advanced glycan endproduct-induced interleukin-6 production and release in an in vitro model of human proximal tubular epithelial cells 201
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 199
Bacterial LPS differently modulates inflammasome gene expression and IL-1β secretion in trophoblast cells, decidual stromal cells, and decidual endothelial cells 199
Emerging Roles of the Complement System at Foeto-maternal Interface 198
A likely association between low mannan-binding lectin level and brain fog onset in long COVID patients 197
The complement system at the embryo implantation site 197
The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine 196
MBL interferes with endovascular trophoblast invasion in pre-eclampsia. 194
Overview of procalcitonin in pregnancy and in pre-eclampsia 193
Differential capability of clinically employed dermal regeneration scaffolds to support vascularization for tissue bioengineering 193
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 190
A non-redundant role of complement protein C1q in normal and adverse pregnancy 179
Proangiogenic properties of complement protein C1q can contribute to endometriosis 178
Endothelial cell supplementation promotes xenograft revascularization during short-term ovarian tissue transplantation 178
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 177
Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels 177
Prognostic Implications of the Complement Protein C1q in Gliomas 177
C1q as pro-angiogenic factor in the context of ovarian tissue transplantation 176
At Embryo Implantation Site IL-35 Secreted by Trophoblast, Polarizing T Cells towards IL-35+ IL-10+ IL-4+ Th2-Type Cells, Could Favour Fetal Allograft Tolerance and Pregnancy Success 176
The use of quantitative real time polymerase chain reaction to quantify some rumen bacterial strains in an in vitro rumen system 174
The C7 component of the complement system localizes to vascular smooth muscle cells and endothelium in human first trimester decidua 171
The expression of complement component C3 is specifically localized in endometrial ectopic tissue and is involved in the endometriotic lesion formation 170
Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I 168
COVID-19, Pre-Eclampsia, and Complement System 162
null 161
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment 160
null 159
Study of the prognostic significance of the protein C1q in carcinomas 158
Pathophysiology of the Complement System at Feto-Maternal Interface 157
Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models 156
null 155
Epigenetic regulation of complement C1Q gene expression 154
null 154
Protection against inflammation- and antiphospholipid antibody-caused fetal loss by the chemokine decoy receptor D6 154
A possible association between low MBL/lectin pathway functionality and microbiota dysbiosis in endometriosis patients 154
null 151
Complement production by trophoblast cells at the feto-maternal interface. 150
Uterine immunity and microbiota: A shifting paradigm 150
P-424 Placental extracellular matrix remodelling in pregnancies by oocyte donation shows similarities with preeclamptic placenta: a pilot study 142
Protective role of complement factor H against the development of preeclampsia 140
Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells 140
The complement protein C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation 138
null 136
Genetic bases of C7 deficiency: systematic review and report of a novel deletion determining functional hemizygosity 132
Prognostic Value of Complement Properdin in Cancer 131
DISTRIBUTION AND FUNCTION OF THE COMPLEMENT PROTEIN C1Q IN MALIGNANT PLEURAL MESOTHELIOMA MICROENVIRONMENT 131
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target 128
Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. 123
null 121
Anti-miRNA therapeutics for uterine fibroids 117
Immunomodulation mediated by a herbal syrup containing astandardized Echinacea root extract: A pilot study in healthy humansubjects on cytokine gene expression 112
Evaluation of levels, specificity and pathophysiology of anti-C1q autoantibodies in pregnancy 111
null 110
First Trimester CD93 as a Novel Marker of Preeclampsia and Its Complications: A Pilot Study 108
null 101
Totale 22.478
Categoria #
all - tutte 61.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.257 0 0 90 84 55 126 83 73 190 134 85 337
2022/20231.772 168 247 139 268 153 277 28 154 193 24 77 44
2023/20241.334 94 66 110 90 105 150 233 187 52 68 100 79
2024/20252.771 65 94 180 201 260 264 186 156 396 367 282 320
2025/20267.332 810 445 540 673 609 600 1.054 204 719 906 482 290
2026/20271.005 409 392 204 0 0 0 0 0 0 0 0 0
Totale 23.373